Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
US$146.21
+1.91+1.32%
After hoursUS$145.56-0.44%
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 126.29亿 | 141.26亿 | 151.94亿 | 159.55亿 | 172.57亿 |
| Gross profit | 72.33亿 | 84.28亿 | 86.79亿 | 92.77亿 | 103.11亿 |
| Operating income | 26.23亿 | 31.17亿 | 32亿 | 29.87亿 | 31.36亿 |
| Net income | 18.66亿 | 18.19亿 | 23.78亿 | 20.31亿 | 24.89亿 |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire